1-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-N-methylmethanamine hydrochloride, 95.0%, 250mg

Methyl-beta-cyclodextrin, min. 98%, 50 g, glass packaging

Ethyl 5-methyloxazole-2-carboxylate, 95.0%, 10g

3-Isopropylphenylboronic acid, 95.0%, 5g

PURMORPHAMINE, 95%, 250mg

Ethyl 5-nitropyrimidine-2-carboxylate, 97.0%, 100mg

3-Indoleacetonitrile>98.0%(GC)25g

1-(9H-Fluoren-9-yl)-3,6-dioxo-2,9-dioxa-4,7-diazaundecan-11-oic acid, 97%, 10g

tert-Butyl 4-(4-bromo-3-(difluoromethyl)-1H-pyrazol-1-yl)piperidine-1-carboxylate, 95.0%, 250mg

5-Ethoxypyrrolidin-2-one, 100mg

methyl 5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylate, 95.0%, 500mg

3,3-Difluoropropan-1-ol, 98%, 100mg

5-(3,4-dimethyl-5-isoxazolyl)-2-furansulfonyl chloride, 95.0%, 1g